- 英文名称((S)-3-Amino-3-Carboxypropyl)(((2S,3S,4R,5R)-5-(6-Amino-9H-Purin-9-yl)-3,4-Dihydroxytetrahydrofuran-2-yl)Methyl)(Methyl)Sulfonium Iodide
- 中文名称S-腺苷基-L-蛋氨碘盐
- IUPAC名称((S)-3-amino-3-carboxypropyl)(((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(methyl)sulfonium iodide
- 其它别名S-Adenosyl-L-Methionine Iodide; S-Adenosyl-L-Methionine (Iodide); [(3S)-3-Amino-3-Carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-Dihydroxyoxolan-2-Yl]Methyl]-Methylsulfanium; Iodide; 5'-[[(3S)-3-Amino-3-Carb
- CAS编号3493-13-8
- MFCD编号:MFCD00043192
- EINECS号:222-486-5
- 分子式:C15H23IN6O5S分子量:526.36
- 产品CID: 1353862
- 产品分类生物化工 → 氨基酸及其衍生物 → 蛋氨酸类衍生物
- 相似结构搜索
- InChIKey: XQMWYLXPEGFCFT-XKGORWRGSA-N
- InChI=1S/C15H22N6O5S.HI/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21;/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25);1H/t7-,8+,
- 计算化学: 氢键受体数11.0氢键供体数5.0可旋转键数7.0
欧盟法规
ECHA物质C&L通报REACH预注册上下游产品
CAS号74-88-4 碘甲烷 | CAS号979-92-0 S-腺苷-L-高半胱氨酸📜碘甲烷,S-(5'-腺苷)-L-高半胱氨酸置于anion Methyltransferase From Aspergillus Clavatus体系中,化学反应 20.0H,反应生成 S-腺苷基-L-蛋氨碘盐
参考文献:用于从卤代烷烃中混杂合成 S-腺苷甲硫氨酸类似物的阴离子甲基转移酶的底物分析
标题:用于从卤代烷烃中混杂合成 S-腺苷甲硫氨酸类似物的阴离子甲基转移酶的底物分析
摘要:普遍存在的共底物s-腺苷甲硫氨酸 (Sam) 的非天然类似物难以获得,但可用于具有高选择性的各种分子的酶促功能化.我们研究了阴离子甲基转移酶家族中 Sam 类似物的混杂合成.已鉴定出几种混杂酶,它们可从廉价且容易获得的卤代烷烃合成非天然共底物.这为选择性烷基化化学开辟了新途径.
DOI:10.1002/cbic.202100632
海关参考信息
- 2905122000-异丙醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇
2905399001-1,3-丙二醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-10391166-B2
优先权日:2013-02-18
标 题:Short oligonucleotides as vaccine adjuvants and therapeutic agents
发明人:IYER RADHAKRISHNAN P
权利人:SPRING BANK PHARMACEUTICALS INC; SPRING BREAK PHARMACEUTICALS INC
摘要:The invention provides a method of treating a microbial infection in a subject and a method of improving an immune system response in a subject against a disease, condition, infection, or virus thereof, by administering an effective amount of a nucleoside, short oligonucleotide compound or an analog thereof, or a pharmaceutically acceptable salt, racemate, enantiomer, diastereomer, geometric isomer, or tautomer thereof. In addition, the invention provides methods for treating or preventing a viral infection, bacterial infection, parasitic infection, or fungal infection in a subject (such as, a human). The compounds of the invention include, for example, di-, and trinucleotide compounds as provided herein. The compounds of the invention are useful for different therapeutic applications including, such as, prophylactics and therapeutics. The invention also provides design and synthesis of a compound that is useful for various therapeutic applications as mentioned herein.